Score Breakdown
Dilution Forecast
Market Data
Institutional Holdings
Short Interest
Recent SEC Activity
Recent News
Related Stocks — MEDIUM Risk
Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:
Track NYMXF dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.
⚠️ Not financial advice. Do your own research before making any investment decisions.
🔔 Track NYMXF — Get alerts when the score changes →As of August 28, 2026, Nymox Pharmaceutical Corporation (NYMXF) has a DilutionWatch DilutionScore of 39/100, rated MEDIUM dilution risk. Nymox Pharmaceutical Corporation has a market capitalization of $13.76M, 94.54M shares outstanding.
This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.
Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles: